Daporinad
| CAS No. | 658084-64-1 | Cat. No. | BCP01909 |
| Name | Daporinad | ||
| Synonyms | APO-866;APO 866;APO866;FK-866;FK 866;FK866;1198425-96-5; | ||
| Formula | C24H29N3O2 | M. Wt | 391.51 |
| Description | Daporinad, also known as APO-866 and FK866, is a small molecule with potential antineoplastic and antiangiogenic activities. NMPRTase inhibitor APO866 binds to and inhibits nicotinamide phosphoribosyltransferase (NMPRTase), inhibiting the biosynthesis of nicotinamide adenine dinucleotide (NAD+) from niacinamide (vitamin B3), which may deplete energy reserves in metabolically active tumor cells and induce tumor cell apoptosis. In addition, this agent may inhibit tumor cell prioduction of vascular endothelial growth factor (VEGF), resulting in the inhibition of tumor angiogenesis. | ||
| Pathways | Protease/Metabolic Enzyme Others Pathway | ||
| Targets | Autophagy Nampt | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.